Evidence map›Paper›PMID 37836686›Full record

ArticleMolecules (Basel, Switzerland)2023

Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2).

Fumei Shi, Yilan Chen, Chuanheng Dong, Jiajia Wang, Chunman Song, Yalin Zhang, Zhen Li, Xianqiang Huang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Long-term exposure to PMScientific reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fumei ShiSchool of Life Science, Liaocheng University, Liaocheng 252000, China.ORCID 0009-0000-7272-3820
Yilan ChenSchool of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252000, China.
Chuanheng DongSchool of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252000, China.
Jiajia WangSchool of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252000, China.
Chunman SongSchool of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252000, China.
Yalin ZhangSchool of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252000, China.
Zhen LiSchool of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252000, China.ORCID 0000-0002-4105-5492
Xianqiang HuangSchool of Chemistry and Chemical Engineering, Liaocheng University, Liaocheng 252000, China.

Funding

National Innovation and Entrepreneurship Training Program for College Students CXCY2022026National Natural Science Foundation of China No. 22201116Natural Science Foundation of Shandong Province No. ZR2023MB018, ZR2022QB066 and ZR2021QB127
6 · The paper itself

Abstract

Polyoxometalates (POMs) exhibit unique structural characteristics and excellent physical and chemical properties, which have attracted significant attention from scholars in the fields of anticancer research and chemotherapy. Herein, we successfully synthesized and structurally characterized two novel polyoxovanadates (POVs), denoted as POVs-

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsTransition ElementsApoptosisHumansMitochondriaReactive Oxygen SpeciesReactive Oxygen SpeciesTransition Elementsanticancerapoptosishuman hepatocellular carcinomasimidazole ligandspolyoxovanadates

Identifiers

PMID37836686
PMCPMC10574323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.